HOME >> BIOLOGY >> NEWS
SNMTS provides $50,000 in 2007 Paul Cole, Mickey Williams Minority Student Technologist Scholarships

o start encouraging minority students to pursue a nuclear medicine profession," noted Mensah.

Receiving one-year Mickey Williams Minority Student scholarships were Theresah Semana, Ferris State University, Big Rapids, Mich.; Derrick Turner, University of Cincinnati, Cincinnati, Ohio; and John Williams, Triton College, River Grove, Ill. The Mickey Williams Minority Student scholarships are made possible through contributions from 2006 Corporate Friends and supporters of the PDEF: Biogen Idec, Capintec Inc., GE Healthcare, Mallinckrodt and MDS Nordion.

Additionally, 30 individuals were named recipients of Paul Cole scholarships, each providing $1,000 to students enrolled in associate, baccalaureate or certificate programs in nuclear medicine technology. These scholarships are based on financial need, statements of goals, academic performance and program director recommendations. Funded by the Education and Research Foundation for SNM, the Paul Cole scholarship was established in memory of Paul Cole, a champion of student education who died in 1986 while serving as SNMTS president. SNM's Central Chapter funded two of these 2007 scholarships.

The 30 Paul Cole Scholarship recipients and their college affiliations are listed here.

Baccalaureate Program

  • Bayley Hicks, Melanie Lee and Andrea Mason, all at the University of Arkansas for Medical Sciences, College of Health Related Professions, Little Rock, Ark.

  • Sarah Pyatt and Kathleen Linehan, both at Indiana University, Indianapolis
  • Lisa Meyer, University of Iowa Hospitals and Clinics, Iowa City

  • Danielle Rill, Johns Hopkins Schools of Medical Imaging, Baltimore, Md.

  • Dennis Flood (supported by SNM's Central Chapter) and Brooke Whitcher, both at the Mayo School of Health Sciences, Rochester, Minn.
  • Jessica Sharp, University of Nebraska Medical Center, Omaha

  • Tra
    '"/>


Contact: Maryann Verrillo
mverrillo@snm.org
703-653-6773
Society of Nuclear Medicine
6-Mar-2007


Page: 1 2 3

Related biology news :

1. Patients undergoing PET/CT may want to pass on that cup of coffee, according to SNMTS study
2. Female gender provides an advantage in renal diseases
3. Forecasting system provides flood warnings to vulnerable residents of Bangladesh
4. Genomics study provides insight into the evolution of unique human traits
5. Study provides new data about the laws governing embryo development in organisms
6. Sea anemone genome provides new view of our multi-celled ancestors
7. Latest data shows MabThera provides significant, sustained relief from symptoms of RA
8. Understanding the global carbon budget -- Woods Hole Research Center expert provides insights
9. Nanotechnology provides green path to environmentally sustainable economy
10. American Association for Cancer Research provides support for promising cancer scientists
11. Life-long learning -- nature provides natural inspiration for education

Post Your Comments:
(Date:12/17/2014)... 2014  HITLAB SM announced today its ... to confirm its adherence to current U.S. Food ... HITLAB to conduct regulated smart device and smart ... patient safety and research quality. "HITLAB ... and delivery with innovative technology," said Laura ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ... "Global Chemical Sensor Market 2015-2019" report to ... One major trend upcoming in ... sensors in biomedical applications. Chemical sensors help in ... diagnosis during surgical procedures. The Global Chemical Sensor ...
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology ... system measures the overall facial feature of a ... the distance between eyes. Facial recognition is used ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
(Date:12/17/2014)... Bellingham, Washington, USA (PRWEB) December 16, 2014 ... Kirstin Baum, manager at Philipps- Universität Marburg’s Department ... optics and photonics, in the newly released ... 2015-2016. “And never be too shy to ask ... STEM (science, technology, engineering, and mathematics) occupations ranging ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... primary commercial focus on China , ... C meeting with the U.S. Food and Drug Administration ... February 2015.  During this meeting the Company will seek ...
(Date:12/15/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology,  today celebrated continued ... its exVive3D TM Human Liver Tissue.  The ... commercial release on November 18, has been recognized ... awards for innovation. Most recently, on ...
Breaking Biology Technology:Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3
Cached News: